z-logo
open-access-imgOpen Access
The Impacts of Prepared Plasma-Activated Medium (PAM) Combined with Doxorubicin on the Viability of MCF-7 Breast Cancer Cells: A New Cancer Treatment Strategy
Author(s) -
Setareh Zahedian,
Azadeh Hekmat,
Saeed Hesami Tackallou,
M. Ghoranneviss
Publication year - 2022
Publication title -
reports of biochemistry and molecular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.467
H-Index - 8
ISSN - 2322-3480
DOI - 10.52547/rbmb.10.4.640
Subject(s) - mcf 7 , doxorubicin , breast cancer , cancer , cancer research , oncology , medicine , chemotherapy , human breast

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom